Record profits, disciplined growth—on track for FY27, not accelerating

Delivered ₹72 Cr PBT (implied from ₹53.7 Cr PAT ÷ ~0.75 tax rate). 27% QoQ confirmed.

Delivered ₹4,552 Cr AUM, 16% QoQ, 82% YoY confirmed

Achieved 5.1% ROA and 14% ROE in Q1, zero NPAs consistent with best-in-class claim

Q1 annualized 72 Cr × 4 = ₹288 Cr; on track but dependent on no material slowdown. Guidance reaffirmed.

At 3x leverage and ₹1,700 Cr equity, can sustain ₹5,100 Cr AUM organically. Up to ₹10,000 Cr with 3x leverage requires retained earnings only.

FY27 PBT ₹300 Cr, PAT ₹225 Cr, AUM ₹5,500 Cr all reaffirmed. No acceleration announced. Q1 'stellar' but normalized to 8-10% PAT QoQ—conservative messaging.

₹225 Cr factoring AUM in June vs ₹175 Cr in March; ₹50 Cr QoQ growth. New product at 5% of total AUM. Only 1% of banks/NBFCs offer it—TAM ₹25L Cr per mgmt.

From 100% historically to 1/3 of AUM now; 52 anchor mandates; 2/3 non-APL. Diversification away from parent, reducing concentration risk over time.

FY26: 12%, Q1 FY27: 14%. Target 16% by FY27 end. Leverage plan 1.9x→2.2x→3x enabling ROE lift with stable ROA ~5%.

No equity raise planned. Leverage moving 1.9x→2.2x→3x over time. Equity base ₹1,539 Cr now, ₹1,700 Cr FY27 end via retained profit. Organic growth to ₹10,000 Cr AUM funded by profitability.

Opex as % of assets is 1%, maintained. As book grows, cost-to-income may look lower but true metric is opex 1% of average assets. Will maintain <15% cost-to-income with digital leverage and lean team.

Factoring yields par with channel finance (~12.5% blended). TReDS platform (4-party), bilateral direct (3-party). Insurance broking B2B cross-sell via wholly-owned subsidiary, not underwriting. IRDAI license pending, launch Q4 FY27 or later.

Aspiration and target, but we understand lending is risky. By time we reach ₹10,000 Cr, profitability will be large enough to absorb any shocks. Not committing to nil NPA forever; credit quality priority over growth.

We are a conservative lender. Conservatism reflects in zero NPA and low credit cost. We prioritize sustainable, stable growth over aggressive volumes. 25-30% is healthy.

Deepening = more dealers under existing anchors, new products (factoring alongside channel finance). Widening = new anchors, geographies, MSMEs. Moat: we fill the gap (e.g., dealer needs ₹10 Cr, banks/NBFCs lend ₹8 Cr, we fill ₹2 Cr gap). Supply chain inherently lower credit cost.

No. ₹337 Cr equity in March-April inflated Q1 PBT by ~13%. Normalized growth: 8-10% PAT QoQ, 15-16% AUM QoQ. That is sustainable and maintains credit cost in check.

₹225 Cr factoring AUM in June vs ₹175 Cr in March; ₹50 Cr QoQ growth. Different sectors than supply chain (auto/steel mature on channel finance; factoring in nascent sectors). Dedicated factoring team hired.

Yes. Comprehensive financial solution provider: AIF (wealth mgmt), ARC, GIFT City (international supply chain), insurance broking. Reduce APL dependency (now 1/3, will trend lower). 5-10 yr: cover full spectrum supply chain, lending, equity, broking.

Supply chain has high churn, long gestation (₹7,000 Cr disbursements for ₹4,500 Cr AUM). Needs velocity. Banks/NBFCs don't dissect balance sheets by supply chain vs non-supply chain; credit quality top-notch. Market still niche; only ~1% institutions do it.

Auto has 45-year dealer distribution history; ecosystem is aligned (OEM, dealer, financer, consumer all settled). In nascent sectors (food, pharma, small industries), factoring fills gap. Over time, sectors mature and cycle from channel finance-only model.

Q1 run-rate 72 Cr PBT × 4 = ₹288 Cr (normalizing front-load); mgmt says 'clear visibility at current run rate'. No new risks flagged.

Q1 achieved 7% cost-to-income, 1% opex ratio. Digital leverage and lean team structure support this. No margin pressure flagged.

Maintained Q3, Q4, Q1 at 12.5%. Factoring at par with channel finance; no dilution despite product mix shift.

Company is 4 years old with pristine NPA record, but aspires to scale 5x to ₹10,000 Cr AUM. Lending inherently carries loss risk. If even 1% NPA emerges, profitability halves.

Geopolitical tension reducing incremental working capital requirements for traders and MSMEs. Not a credit loss yet, but limits volume growth. Company is responding by acquiring new customers and expanding products.

Historically 100% dependent on APL Apollo; now 1/3 of ₹4,552 Cr AUM (~₹1,517 Cr). Single group exposure; event risk if parent hits stress.

Leverage was 1.9x March 2026, now 2.2x, targeting 3x by FY30. CAR 32% is strong but will compress as leverage increases. If profitability misses, capital will tighten.

Factoring only ₹225 Cr (5% AUM) after 3 months; insurance broking awaiting IRDAI approval (Q4 target). Execution risk if product-market fit is weak or regulatory approval delayed.